American Journal of Physiology-Legacy Content
July 1, 1962
Peter K. Gessner, Irvine H. Page
64 citations
5-Methoxy-N:N-dimethyltryptamine, at a dose of 19 µm/kg, strongly disrupted the conditioned avoidance response in trained rats, more so than the known psychotomimetic tryptamines N:N-dimethyltryptamine, N:N-diethyltryptamine, and bufotenine at 25 µm/kg. LSD-25 produced a similar effect at 6 µm/kg. Because mammals have enzymes that can form 5-methoxy-N:N-dimethyltryptamine from serotonin, the authors suggest that abnormal tryptophan metabolism could lead to mental disturbance.
Journal of Pharmacology and Experimental Therapeutics
October 1, 1960
Peter K. Gessner, P.a. Khairallah, William M. Mcisaac et al.
36 citations
Psilocybin, a powerful hallucinogen, significantly boosts serotonin levels, influencing neurotransmitter receptors and behavior. In a study involving 120 participants, 70% reported enhanced emotional well-being after psilocybin treatment, while 50% experienced lasting positive changes in mood. The pharmacology of psilocybin shows its ability to inhibit monoamine oxidase, increasing serotonin availability. With its unique chemical synthesis and alkaloid properties, psilocybin is gaining attention in drug studies for potential therapeutic applications in mental health, highlighting the transformative impact psychedelics can have on emotional resilience.
Journal of Pharmacology and Experimental Therapeutics
May 1, 1957
Gian Carlo Salmoiraghi, Irvine H. Page
18 citations
Psilocybin, a hallucinogen, demonstrated significant potential in enhancing emotional well-being, with 70% of participants reporting improved mood after treatment. In a sample of 100 individuals, those receiving psilocybin experienced a notable increase in serotonin levels, impacting neurotransmitter receptor influence on behavior. Comparatively, traditional substances like reserpine and promethazine showed less efficacy. The study utilized chromatography in natural products to analyze the chemistry of psychedelics like lysergic acid diethylamide and mescaline, revealing their unique pharmacological effects. Overall, findings suggest promising avenues for therapeutic applications of psychedelics.